Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Podcast: Stem cell therapy for PD - A new era for managing Parkinson’s disease?
dec 2023 | Bewegingsstoornissen